These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 32508821)

  • 21. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
    Shirasuna K; Karasawa T; Takahashi M
    J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.
    Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
    Front Immunol; 2020; 11():618231. PubMed ID: 33603747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.
    Tian R; Zhu Y; Yao J; Meng X; Wang J; Xie H; Wang R
    Exp Cell Res; 2017 Aug; 357(2):328-334. PubMed ID: 28591554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NLRP3 inflammasome in acute myocardial infarction.
    Toldo S; Abbate A
    Nat Rev Cardiol; 2018 Apr; 15(4):203-214. PubMed ID: 29143812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NLRP3 inflammasome activation in alveolar epithelial cells promotes myofibroblast differentiation of lung-resident mesenchymal stem cells during pulmonary fibrogenesis.
    Ji J; Hou J; Xia Y; Xiang Z; Han X
    Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166077. PubMed ID: 33515677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx.
    Katsnelson MA; Lozada-Soto KM; Russo HM; Miller BA; Dubyak GR
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C83-C100. PubMed ID: 27170638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis.
    Pan XC; Liu Y; Cen YY; Xiong YL; Li JM; Ding YY; Tong YF; Liu T; Chen XH; Zhang HG
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC.
    Sušjan P; Lainšček D; Strmšek Ž; Hodnik V; Anderluh G; Hafner-Bratkovič I
    FASEB J; 2020 Aug; 34(8):11068-11086. PubMed ID: 32648626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
    Buckley LF; Libby P
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
    Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
    Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney.
    Kim YG; Kim SM; Kim KP; Lee SH; Moon JY
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
    Zhong Z; Sanchez-Lopez E; Karin M
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRP3 Inflammasome in Cardioprotective Signaling.
    Zuurbier CJ
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):271-275. PubMed ID: 31356546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling.
    Suetomi T; Miyamoto S; Brown JH
    Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H877-H890. PubMed ID: 31441689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of NLRP3 Inflammasomes in Neuroinflammation Diseases.
    Lin S; Mei X
    Eur Neurol; 2020; 83(6):576-580. PubMed ID: 33202405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome.
    Bracey NA; Gershkovich B; Chun J; Vilaysane A; Meijndert HC; Wright JR; Fedak PW; Beck PL; Muruve DA; Duff HJ
    J Biol Chem; 2014 Jul; 289(28):19571-84. PubMed ID: 24841199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
    Kim JK; Jin HS; Suh HW; Jo EK
    Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Anders HJ; Suarez-Alvarez B; Grigorescu M; Foresto-Neto O; Steiger S; Desai J; Marschner JA; Honarpisheh M; Shi C; Jordan J; Müller L; Burzlaff N; Bäuerle T; Mulay SR
    Kidney Int; 2018 Mar; 93(3):656-669. PubMed ID: 29241624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.